How much funding has TRACON Pharmaceuticals raised?

TRACON Pharmaceuticals has raised $41.0M in total funding, most recently a Series B round.

Who are TRACON Pharmaceuticals's investors?

TRACON Pharmaceuticals's investors include Nextech Invest, Rally Ventures, Arcus Ventures.

When was TRACON Pharmaceuticals founded?

TRACON Pharmaceuticals was founded in 2004.

Where is TRACON Pharmaceuticals headquartered?

TRACON Pharmaceuticals is headquartered in San Diego, California, United States.

What industry is TRACON Pharmaceuticals in?

TRACON Pharmaceuticals operates in Biotech.

How many employees does TRACON Pharmaceuticals have?

TRACON Pharmaceuticals has 11-50 employees.

TRACON Pharmaceuticals

IPO

Public · San Diego, United States · Founded 2004 · $41.0M raised

Biotech

Headquarters: San Diego, California
Employees: 11–50
Founded: 2004
Business Model: B2B
Website: traconpharma.com

Total Funding: $41.0M
Last Round: $27.0M Series BApr 2011
Rounds: 2
Type: Public

About

TRACON Pharmaceuticals, Inc. (OTC: TCON) is a San Diego-based clinical-stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for oncology and ophthalmology, including cancer and age-related macular degeneration. Incorporated in Delaware in October 2004 under the name Lexington Pharmaceuticals, the company rebranded as TRACON and went public. TRACON's drug development strategy centers on leveraging its cost-efficient clinical development model to in-license and advance promising compounds through clinical trials. The company has collaborated with major pharmaceutical and biotechnology partners to co-develop and commercialize oncology assets.

Summary

TRACON Pharmaceuticals is a Biotech company based in San Diego, United States, founded in 2004. It has raised $41.0M in total across 2 rounds, most recently a $27.0M Series B round in Apr 2011. Investors include Nextech Invest, Rally Ventures and Arcus Ventures.